Medical News
University News
Medical Publications
Resources
Medical News Releases > WUSTL in the News >


WUSTL in the News Spotlight


(Excerpted from USA Today, Wednesday, Feb. 2, 2005)

Drugs for Alzheimer's agitation often ineffective, study says

Antidepressants, mood stabilizers not designed for older patients

Many drugs commonly used to calm the agitation, delusions and other behavioral problems associated with advanced Alzheimer's disease don't work well, a study reports today.

As many as 80% of Alzheimer's patients' symptoms include not only memory loss but also aggression, wandering, hallucinations and other disruptive behavior.

"As the disease progresses, the agitation and other problems are very difficult for families to deal with," says John Morris, an Alzheimer's expert at Washington University in St. Louis.

The study, published in The Journal of the American Medical Association, found that antidepressants such as Prozac and mood stabilizers such as Tegretol offer little or no relief for the behavioral symptoms of Alzheimer's. These drugs were designed for younger patients and not for older Alzheimer's patients, says William Thies of the Chicago-based Alzheimer's Association.

But doctors are under enormous pressure to prescribe drugs to treat such behaviors. "Caregivers want a magic pill," says Kaycee Sink, lead author of the paper. "What our study showed is that there is no magic pill."

Sink, who is a geriatric expert at Wake Forest University in Winston-Salem, N.C., and her colleagues analyzed 29 studies on drugs typically used to quell behavioral problems in Alzheimer's disease.

The team found that drugs approved to treat the memory difficulties of Alzheimer's did seem to ease the behavioral problems. But Morris says patients who are very disruptive often don't get enough relief from these drugs, called cholinesterase inhibitors.




Appeared in:

Click headline below to view news story as originally posted on an external Web site.

•   Drugs for Alzheimer's agitation often ineffective, study says

Antidepressants, mood stabilizers not designed for older patients

USA Today, Wednesday, Feb. 2, 2005
Byline: Kathleen Fackelmann

•   Alzheimer's Troubling Behaviors Hard to Treat

Forbes.com, Wednesday, Feb. 2, 2005
Byline: Serena Gordon, HealthDay Reporter


Story also ran in 3 others:  RedNova.com, HealthDayNews and HealthCentral.com
(Note: Links do not imply an endorsement; some sites require registration; links may change or become broken over time.)


Washington University in St. LouisSchool of Medicine

Affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital, members of BJC HealthCare.

Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.













Related Information
Media Assistance:

Jim Dryden
Assoc. Dir. of Broadcast Services
jdryden@wustl.edu

(314) 286-0110
Subject Matter Experts:

Related Groups:

Schools:
School of Medicine

Departments:
Neurology

Programs:
Geriatrics

- View All Groups

Related Topics:
Aging
Aging and Mental Health
Alzheimer's Disease / Memory
Caregiving for Older Americans
Medical / Pharmaceutical Research Issues
Mental Health / Illness
Productive Aging

- View All Topics

Revised:

Wednesday, June 15, 2005


  Print ready page